|
|
|
While
diseases of the central nervous system can be difficult to
recognize, they have devastating effects on people's lives.
|
 |
| |
 |
Zoloft treats depression and panic disorder as well as obsessive-compulsive disorder with strong efficacy and a favorable safety and tolerability profile. It is taken orally once a day with rapid effectiveness in relieving depression and anxiety symptoms.
|
| |
|
|
 |
| |
 |
Sermion is indicated for acute and chronic cerebral vascular-metabolic disorders caused by arteriosclerosis, cerebral thrombosis and embolism, transitory cerebral ischemia, acute and chronic peripheral vascular-metabolic disorders, headache, adjuvant treatment of arterial hypertension and, parenterally, of hypertensive crises.
|
| |
|
|
 |
| |
 |
Zeldox (Ziprasidone Hydrochloride Capsules) is a new atypical antipsychotic with the potential benefit beyond symptoms control for schizophrenias. It can provide not only rapid and sustained control of positive and negative symptoms, but also improving symptoms of cognition, depression and anxiety in schizophrenia. Zeldox can reduce
the risk of relapse with long-term use. At the same time, Zeldox provides patients with low incidence of EPS and prolactin elevation. Most important, Zeldox offers patients with weight-neutral and favorable metabolic profile including lipids and insulin to avoid diabetes and CV risks. Until 2006 Q3, Zeldox has been launched in 89
countries all over the world with more than 7 million prescriptions in 1.75 million patients.
|
| |
|
|
|
|
|
 |
|
